AP-HM tumour tissue bank: Molecular signature of gliomas;Tumorothèque de l'AP-HM: Cartographie moléculaire des gliomes

Medecine/Sciences

Volumn 22, Issue SPEC. ISS. 1, 2006, Pages 54-59

  Figarella Branger, Dominique ^a,b   Colin, Carole ^a   Chinot, Olivier ^b,c,d   Nanni, Isabelle ^c   Baeza, Nathalie ^a   Fina, Frédéric ^c   Tong, Soutsakhone ^b   Eudes, Nathalie ^a   Quilichini, Benoit ^b   Romain, Sylvie ^c   Metellus, Philippe ^b   Fuentes, Stéphane ^b   Barrié, Maryline ^b   Boucard, Céline ^b   Fraslon, Caroline ^d   Bonavita, Marìe José ^d   Martin, Pierre Marie ^c,d   Ouafik, L'Houcine ^c,d  

^a AIX MARSEILLE UNIVERSITY   (France)

^b TIMONE HOSPITAL   (France)

^c HÔPITAL NORD   (France)

^d ASSISTANCE PUBLIQUE HÔPITAUX DE MARSEILLE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

MOLECULAR MARKER;

ANGIOGENESIS; ASTROCYTOMA; BENIGN TUMOR; CANCER GRADING; CANCER INVASION; CONFERENCE PAPER; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; DNA MICROARRAY; FRANCE; GENE EXPRESSION; GLIOBLASTOMA; GLIOMA; HEALTH CARE FACILITY; HUMAN; MALIGNANT NEOPLASTIC DISEASE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SUPPRESSION SUBTRACTIVE HYBRIDIZATION; SURVIVAL TIME; WORLD HEALTH ORGANIZATION;

EID: 30944433985     PISSN: 07670974     EISSN: None     Source Type: Journal    
DOI: 10.1051/medsci/2006221s54     Document Type: Conference Paper

References (18)

1. Curran WJ, Scott CB, Norton J, et al. Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials. J Natl Cancer Inst 1993; 85: 704-10.
2. Kleihues P, Cavenee WK. World Health Organization: classification of tumors of the nervous system. Lyon: IARC/WHO, 2000.
3. Coons SW, Johnson PC, Scheithauer BW, Yates AJ, Pearl DK. Improving diagnostic accuracy and interobserver concordance in the classification and grading of primary gliomas. Cancer 1997; 79: 1381-93.
4. He J, Mokhtari K, Sanson M, et al. Glioblastomas with an oligodendroglial component: a pathological and molecular study. Neuropathol Exp Neurol 2001; 60: 863-71.
5. Group GM-aTG. Chemotherapy in adult high-grade glioma: a systematic review and meta-analysis of individual patient data from 12 randomised trials. Lancet 2002; 359: 1011-8.
6. Stupp R, Mason WP, van den Bent MJ, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 2005; 352: 987-96.
7. Chinot OL, Barrie M, Frauger E, et al. Phase II study of temozolomide without radiotherapy in newly diagnosed glioblastoma multiforme in an elderly populations. Cancer 2004; 100: 2208-14.
8. Barrié M, Couprie C, Dufour H, et al. Temozolomide in combination with BCNU before and after radiotherapy in patients with inoperable newly diagnosed glioblastoma multiforme. Ann Oncol 2006 (sous presse).
9. Cairncross JG, Ueki K, Zlatescu MC, et al. Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas. J Natl Cancer Inst 1998; 90: 1473-9.
10. Smith JS, Perry A, Borell TJ, et al. Alterations of chromosome arms 1p and 19q as predictors of survival in oligodendrogliomas, astrocytomas, and mixed oligoastrocytomas. J Clin Oncol 2000; 18: 636-45.
11. Hoang-Xuan K, Capelle L, Kujas M, et al. Temozolomide as initial treatment for adults with low-grade oligodendrogliomas or oligoastrocytomas and correlation with chromosome 1p deletions. J Clin Oncol 2004; 22: 3133-8.
12. Hegi ME, Diserens AC, Gorlia T, et al. MGMT gene silencing and benefit from temozolomide in glioblastoma. N Engl J Med 2005; 352: 997-1003.
13. Diatchenko L, Lau VF, Campbell AP, et al. Suppression subtractive hybridization: a method for generating differentially regulated or tissue-specific cDNA probes and libraries. Proc Natl Acad Sci USA 1996; 93: 6025-30.
14. Plate KH, Breier G, Weich HA, Risau W. Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo. Nature 1992; 359: 845-8.
15. Ouafik L, Sauze S, Boudouresque F, et al. Neutralization of adrenomedullin inhibits the growth of human glioblastoma cell lines in vitro and suppresses tumor xenograft growth in vivo. Am J Pathol 2002; 160: 1279-92.
16. Muracciole X, Romain S, Dufour H, Palmari J, Chinot O, Ouafik L, Grisoli F, Figarella-Branger D, Martin PM. PAI-1 and EGFR expression in adult glioma tumors: toward a molecular pronostic classification. Int J Radiat Oncol Biol Phys 2002; 52: 592-8.
17. Boudouresque F, Berthois Y, Martin PM, Figarella-Branger D, Chinot O, Ouafik LH. Angiogenèse et tumeurs cérébrales: rôle de l'adrénomédulline. Bull Cancer 2005, 94: 317-26.
18. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162: 156-9.